AstraZeneca falls as fraud investigation reportedly expands in China (update)
An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read more here.
Chinese authorities probing ‘dozens’ of AstraZeneca executives, Yicai reports
Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global
AstraZeneca: China's investigation into exec separate from medical insurance probe
AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health insurance fraud case also involving the company.
AstraZeneca Falls Most Since 2020 as China Probe Fears Mount
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker.
AstraZeneca Stock Falls on China Probe Fears
AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China chief,
AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
AstraZeneca falls on reports of Chinese probe
Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of senior executives in the company's China subsidiary have been implicated in an insurance fraud case.
AstraZeneca extends losses as Chinese probe widens
AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former executives of the company.
AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
BioSpace15h
AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...
Yicai Global10h
China Sales Decline for Top Car Multinationals as Local EV Brands Thrive
Foreign carmakers are losing ground in the world's biggest auto market. As the Chinese market for combustion engine vehicles shrinks, local automakers such as BYD, Geely Holding Group, and Li Auto ...
pharmaphorum23h
AZ shares weaken as China investigation rumours swirl
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
AstraZeneca says does not comment on media reports as shares slump
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
Over £14bn wiped off AstraZeneca amid China fears
AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...
Yicai Global5d
China's Top 100 Builders Recorded First 2024 Sales Boost in October, CRIC Data Show
Demand was particularly strong in China's four first-tier cities. Beijing, Shanghai, Guangzhou, and Shenzhen saw a 65 percent ...